North Carolina to Receive $150 Million From Purdue-Sackler Opioid Settlement

North Carolina Attorney General Jeff Jackson announced Monday that the state will receive nearly $150 million from the $7.4 billion Purdue Pharma and Sackler family settlement, marking a significant milestone in the state's ongoing efforts to address the opioid crisis.

The settlement, which became officially effective May 1, 2026, represents the culmination of years of litigation against the maker of OxyContin and the family that controlled the company. For North Carolina, the payment brings the state's total opioid settlement recovery to $1.6 billion—resources that will flow to local governments and recovery programs across all 100 counties.

Settlement Terms and North Carolina's Share

The Purdue-Sackler agreement stands apart from other opioid settlements in both scale and scope. Beyond the $7.4 billion financial payment, the settlement includes provisions designed to prevent similar corporate misconduct in the future:

Permanent ban on Sackler opioid sales — The Sackler family is permanently prohibited from selling opioids in the United States, removing one of the most prominent names from the pharmaceutical supply chain.

Document disclosure — More than 30 million internal company documents related to Purdue's opioid business must be made public, providing researchers, journalists, and policymakers unprecedented insight into how the crisis was manufactured.

Payment structure — Purdue is paying $900 million in May 2026 as an initial installment, with the Sackler family contributing $1.5 billion. Payments will continue over 15 years, creating a sustained funding stream rather than a one-time windfall.

North Carolina's $150 million allocation reflects formulas that account for population, overdose death rates, and the volume of prescription opioids distributed within the state. The funds join approximately $1.45 billion previously secured through settlements with other manufacturers, distributors, and pharmacies.

Jackson's Statement on Corporate Accountability

Attorney General Jackson framed the settlement as both a financial recovery and a moral reckoning.

"Purdue and the Sacklers built a business by fueling opioid addiction and knew the harm it was causing," Jackson said. "This settlement is the right outcome after years of legal battles."

The statement reflects a shift in how state attorneys general have approached opioid litigation—from seeking purely financial compensation to demanding structural changes in corporate behavior and public accountability through document disclosure.

Distribution of Settlement Funds

North Carolina's approach to opioid settlement funds has emphasized local control and evidence-based spending. The $1.6 billion total will be distributed through several channels:

Local government allocations — Counties and municipalities receive direct payments based on formulas that weight population and documented opioid impact. Local officials have discretion to fund treatment programs, prevention initiatives, and recovery services tailored to community needs.

State-administered programs — The North Carolina Department of Health and Human Services oversees grants to community-based organizations, crisis response teams, and treatment providers in underserved areas.

Abatement fund oversight — An advisory commission monitors spending to ensure funds address the crisis rather than replacing existing budget allocations.

Recent NCDHHS announcements illustrate how settlement dollars are being deployed:

• $5.7 million to 12 community organizations expanding treatment in rural and underserved communities (April 2026)
• $1.5 million expanding Law Enforcement Assisted Diversion (LEAD) programs to seven additional law enforcement agencies (March 2026)
• Crisis co-response teams pairing behavioral health clinicians with emergency responders
• Mobile outreach units bringing medication-assisted treatment to remote counties
• Transitional recovery housing for individuals leaving incarceration

Context: North Carolina's Opioid Crisis

North Carolina has experienced the full arc of the opioid epidemic, from early prescription opioid overuse through the current fentanyl-dominated phase. While recent data shows encouraging trends—emergency department visits and overdose deaths have declined from peak levels—the state still recorded approximately 4,100 drug overdose deaths in 2024.

More than 1.4 million North Carolinians currently struggle with substance use, according to state health officials. The crisis has touched every region, though impacts vary:

Urban centers — Cities like Charlotte, Raleigh, and Greensboro have seen high absolute numbers of overdose deaths and have developed relatively robust treatment infrastructure.

Rural counties — Eastern and western North Carolina face severe treatment deserts, with some residents driving 90 minutes or more to reach the nearest medication-assisted treatment provider.

Justice-involved populations — North Carolina jails and prisons house thousands of individuals with untreated opioid use disorder, creating cycles of incarceration and overdose risk upon release.

Comparison to Other States

North Carolina's $150 million payment ranks among the larger state allocations from the Purdue settlement, reflecting both its population size and significant documented opioid impact. For context:

• New Jersey: $125 million
• South Carolina: $73 million
• Nevada: $58 million
• Nebraska: $19.7 million
• West Virginia: $50+ million

The variation reflects both population differences and the severity of the crisis in each state. West Virginia, despite its smaller population, has consistently ranked among the highest states for overdose death rates, resulting in substantial settlement allocations relative to size.

Challenges in Settlement Fund Deployment

While the $1.6 billion total represents unprecedented resources, North Carolina faces significant challenges in deploying funds effectively:

Geographic barriers — Rural counties lack treatment infrastructure, requiring mobile services or telehealth solutions that don't fully replicate in-person care.

Workforce shortages — Addiction medicine specialists, psychiatrists, and certified peer recovery coaches remain scarce, particularly in underserved regions.

Sustainability concerns — Settlement payments span 15 years, creating planning challenges. Programs initiated with settlement funds need transition plans to sustainable funding or face closure when payments end.

Accountability and measurement — Ensuring funds achieve measurable outcomes rather than simply expanding existing programs requires robust evaluation systems.

Looking Forward

The Purdue settlement's effectiveness will ultimately be measured not in dollars collected but in lives saved. For North Carolina, the $150 million payment adds to resources already flowing into communities—expanding treatment capacity, funding prevention programs, and supporting recovery services.

Whether these investments reverse the devastating trends of the past two decades depends on sustained commitment, effective implementation, and continued focus on the communities most affected by the crisis.

The settlement closes one chapter of the opioid story—the legal reckoning with the companies that profited from addiction. The harder work of healing communities and preventing future tragedies continues.

---

If you or someone you know is struggling with opioid addiction, help is available. Visit SAMHSA's treatment locator or call 1-800-662-4357. For immediate overdose response, naloxone is available without prescription at most North Carolina pharmacies. Explore our guides to opioid addiction treatment and medication-assisted recovery.